Evidence map›Paper›PMID 32521750›Full record

ReviewInternational journal of environmental research and public health2020

Intense Sweeteners, Taste Receptors and the Gut Microbiome: A Metabolic Health Perspective.

Alexandria Turner, Martin Veysey, Simon Keely, Christopher J Scarlett, Mark Lucock, Emma L Beckett

Open access · goldAbstract readReview
In one paragraph

Review in International journal of environmental research and public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Do Gut Microbes Taste?Nutrients · 2021
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Alexandria TurnerSchool of Environmental and Life Sciences, University of Newcastle, Ourimbah 2258, Australia.
Martin VeyseySchool of Medicine and Public Health, University of Newcastle, Ourimbah 2258, Australia.
Simon KeelySchool of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan 2308, Australia.
Christopher J ScarlettSchool of Environmental and Life Sciences, University of Newcastle, Ourimbah 2258, Australia.
Mark LucockSchool of Environmental and Life Sciences, University of Newcastle, Ourimbah 2258, Australia.
Emma L BeckettSchool of Environmental and Life Sciences, University of Newcastle, Ourimbah 2258, Australia.
Hunter Water · AUHunter Medical Research Institute · AUUniversity of Hull · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intense sweeteners (IS) are often marketed as a healthier alternative to sugars, with the potential to aid in combating the worldwide rise of diabetes and obesity. However, their use has been counterintuitively associated with impaired glucose homeostasis, weight gain and altered gut microbiota. The nature of these associations, and the mechanisms responsible, are yet to be fully elucidated. Differences in their interaction with taste receptors may be a potential explanatory factor. Like sugars, IS stimulate sweet taste receptors, but due to their diverse structures, some are also able to stimulate bitter taste receptors. These receptors are expressed in the oral cavity and extra-orally, including throughout the gastrointestinal tract. They are involved in the modulation of appetite, glucose homeostasis and gut motility. Therefore, taste genotypes resulting in functional receptor changes and altered receptor expression levels may be associated with metabolic conditions. IS and taste receptors may both interact with the gastrointestinal microbiome, and their interactions may potentially explain the relationship between IS use, obesity and metabolic outcomes. While these elements are often studied in isolation, the potential interactions remain unexplored. Here, the current evidence of the relationship between IS use, obesity and metabolic outcomes is presented, and the potential roles for interactions with taste receptors and the gastrointestinal microbiota in modulating these relationships are explored.

Indexed as

Gastrointestinal MicrobiomeSweetening AgentsHumansObesityReceptors, G-Protein-CoupledTasteReceptors, G-Protein-CoupledSweetening Agentsgut hormonegut microbiomemetabolismnon-nutritive sweetenerobesitysweetenertaste receptor

Identifiers

PMID32521750
PMCPMC7312722
OpenAlexW3032912802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.